News
18h
TipRanks on MSNAbbVie and Genmab’s Promising Study on Epcoritamab for Non-Hodgkin LymphomaThe study involves testing epcoritamab, administered subcutaneously, in combination with oral and intravenous anti-neoplastic agents. These include drugs like lenalidomide, ibrutinib, and polatuzumab ...
Stephen Lea, 33, from Bootle in Merseyside, was fit and healthy when he started experiencing back pain last year.
8d
Verywell Health on MSNWhat Is Stage 3 Lymphoma?Stage 3 lymphoma is a lymphatic cancer that has spread to lymph nodes above and below the diaphragm. Learn its symptoms, ...
1h
News-Medical.Net on MSNInsecticide exposure could impair mental function in older adultsThe study investigates the link between pesticide exposure and cognitive impairment in older adults, suggesting a need for ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...
Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- accounts for 20% to 30% of all non-Hodgkin lymphoma cases. The indolent ...
The 33-year-old initially thought the pain could be due to the long hours he was working - but it was a sign of something much more sinister ...
How does ARV-393 contribute to lymphoma treatment? ARV-393 aims to provide effective treatment options for patients with relapsed/refractory non-Hodgkin lymphoma through targeted protein degradation.
Cancer-hunting antibodies coupled with a natural compound found in soil microbes proved a powerful combination against an aggressive type of blood cancer, according to a new study from scientists at ...
Treatment for non-Hodgkin lymphoma Your treatment depends on several factors. These include what type of NHL you have and where it has spread to (the stage). It also depends on how fast it is growing ...
Paul Harvey’s iconic sign-off, “And now you know the rest of the story,” captivated more than 24 million weekly listeners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results